The Korea Advanced Institute of Science and Technology (KAIST) said Monday that its research team has developed a new type of protein treatment to reduce the side effects, including severe inflammation, from existing Alzheimer's treatments.Alzheimer's disease is the leading cause of senile dementia
Daewoong Pharmaceuticals said on Monday that its potassium-competitive acid blockers (P-CAB)-based drug, Fexuclue (ingredient name: Fexuprazan hydrochloride), received an adaptation certificate for improving gastric mucosal lesions of acute and chronic gastritis.As a result, Fexuclue has secured two
HanAll Biopharma said it has applied for a phase 3 trial of the autoimmune disease drug HL161 (ingredient: batoclimab) in Japan.In a public disclosure on Friday, HanAll said it submitted Clinical Trial Notification (CTN) for the phase 3 study of HL161 to treat myasthenia gravis (MG) in Japan.Japan’s
Ildong Pharmaceutical’s oral Covid-19 treatment Xocova (pipeline name: S-217822) will have the first to get Japan’s emergency use authorization (EUA) to score EUA in Korea, an official drug regulator said.As the EUA in Japan is making slow progress, it will be almost impossible to obtain EUA in Kore
Peptron said Monday that it has received phase 3 IND approval from the U.S. FDA for its proprietary ultrasonic spray drying SmartDepot technology as a cerebrovascular therapeutic, Presedin (PT320), being co-developed with Invex.PT320 implements an ideal drug release pattern for therapeutic effects a
Breast cancer patients and their families increasingly demand the government’s quick approval for Enhertu (ingredient: trastuzumab deruxtecan), a new breast cancer treatment.On the online petition site of the National Assembly on Tuesday, a petitioner urged the government to approve Enhertu. It is t
Korea's new virus cases fell below 140,000 on Friday, but daily Covid-19 deaths reached the highest figure in more than three months amid the lingering resurgence driven by a highly contagious Omicron subvariant, BA.5.The country added 138,812 new Covid-19 infections, including 465 cases from abroad
HLB said Friday that the first global clinical phase 3 results of its liver cancer drug, rivoceranib, and camrelizumab, will be presented orally at the proffered paper session of the European Society for Medical Oncology (ESMO) on Sept. 10.Proffered papers are verbally presented in front of experts
SD Biosensor signed a contract to provide the Japanese government with Covid-19 diagnostic kits and influenza-Covid-19 simultaneous diagnostic kits worth 148.3 billion won ($111.9 million).The company will supply these kits from Thursday to Nov. 30.According to SD Biosensor, the simultaneous diagnos
Korea’s biopharmaceutical companies and diagnosis kit makers showed mixed performances in the second quarter, depending on their CMO (contract manufacturing organization) businesses and the spreading curve of Covid-19, industry watchers said Friday.Samsung Biologics and Celltrion Healthcare stood ou
Like its predecessors, the Yoon Suk-yeol government made an ambitious promise to ease regulations to revitalize corporate activities.When Yoon was president-elect in March, he pledged to make a hotline to communicate with business lobby groups directly. Prime Minister Han Duck-soo also showed his st
Physicians are widely prescribing the antidiabetic drug metformin, antiparasitic drug ivermectin, and antidepressant fluvoxamine despite their insufficient evidence for Covid-19 treatment.However, in a randomized, placebo-controlled trial, U.S. researchers found that none of the three medicines coul
Celltrion said it signed a contract manufacturing organization (CMO) contract with Teva Pharmaceutical to supply raw materials for Ajovy, a migraine drug.The contract is worth about 110 billion won ($82.8 million), 5.8 percent of Celltrion’s 2021 sales and its period is from Aug. 19, 2022, to March
The Ministry of Food and Drug Safety said it would put off enhancing insulin delivery rules by six months because there was insufficient insulin to go around.On Thursday, the MFDS said it would extend the “guidance period” for insulin products by six months until Jan. 17, 2023, before applying reinf
You might think that foreign medical doctors may not easily choose to work in Korea, but Italian-born Paola Russo, who now leads a function within the pharmacovigilance group at Samsung Bioepis, seems to be an exception.“Sharing a living dream with Samsung Bioepis, I joined wholeheartedly with great
Amid the rising reinfections of Covid-19, the quarantine authorities on Thursday recommended a booster shot to people who have previously tested positive for the virus.The Corona 19 Vaccination Response Promotion Team has changed the vaccination regulation to recommend a booster shot for high-risk g
Helixmith said Thursday that it has been informed of the recommendation by the Independent Data Monitoring Committee (IDMC) following the panel’s interim analysis of its diabetic peripheral neuropathy (DPN) treatment, Engensis (VM202).The IDMC reviewed the interim analysis data and the results of He
GSK Korea has again set about to reduce its workforce through an early retirement program (ERP).According to industry insiders, GSK recently announced the ERP plan for its sales representatives, saying it would accept applications from Aug. 17-30. It is the third ERP the Korean offshoot of GSK has c
The number of deaths from Covid-19 among children aged 18 or younger reached 44 as of Thursday, the government said Thursday.On Thursday, the Central Disease Control Headquarters (CDCH) released the analysis on Covid-19 deaths among children and adolescents aged 18 or younger.The nation reported the
Korean Journal of Radiology (KJR) ranked top among radiology journals using country or continent names by recording the highest impact factor (IF) last year.IF, also known as journal impact factor (JIF), is a scientometric index calculated by Clarivate that reflects the mean number of citations of a